- Sarepta's FDA decision date; Flare gets Anna Protopapas as CEOPlus news about Deerfield, InflaRx, Praxis, Nuvectis, Pyxis Oncology, Vistagen, Arcutis Biotherapeutics and Nxera. 🔎 FDA to decide on future of Sarepta exon-skipping drugs by end of February: Th…Endpoints · 27d ago↗ source
- Beeline ups its Series A round for immune drug work<figure><div><img src="https://imgproxy.divecdn.com/4FSYxYVR65mzzE0lNMMPQjdujTL0_B50-03lC1bSrS8/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS8yWEtHQ0JZLmpwZw==.webp"/></div></f…BioPharma Dive · 28d ago↗ source
- STAT+: All of Us tests a new approach to collect real-world data for researchThe NIH All of Us Research Program has secured thousands of electronic medical records through an innovative use of patient data-sharing networks